Fig. 3: The oncoplot shows all the somatic mutations identified in PALB2 tumours in comparison to BRCA1 and BRCA2 tumours in the top 20 mutated genes commonly associated with breast cancer (with prevalence indicated as reported previously by 18).
From: Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses

The lower bottom panel represented somatic alterations in PALB2 tumours identified in other additional genes. Each column represented a sample.